Tower Research Capital LLC (TRC) - SCOPUS BIOPHARMA INC ownership

SCOPUS BIOPHARMA INC's ticker is SCPS and the CUSIP is 809171101. A total of 29 filers reported holding SCOPUS BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SCOPUS BIOPHARMA INC
ValueSharesWeighting
Q3 2022$6,000
-50.0%
26,533
-5.8%
0.00%
Q2 2022$12,000
+100.0%
28,158
+206.5%
0.00%
Q1 2022$6,000
-33.3%
9,187
+60.1%
0.00%
Q4 2021$9,000
-90.4%
5,737
-74.7%
0.00%
-100.0%
Q3 2021$94,000
+370.0%
22,718
+701.3%
0.00%
+100.0%
Q2 2021$20,000
+900.0%
2,835
+1339.1%
0.00%
Q1 2021$2,000
-90.0%
197
-85.6%
0.00%
-100.0%
Q4 2020$20,0001,3700.00%
Other shareholders
SCOPUS BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
M&R CAPITAL MANAGEMENT INC 76,819$33,0000.01%
VANGUARD GROUP INC 54,649$24,0000.00%
UBS Group AG 100$00.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32,966$14,0000.00%
Compagnie Lombard Odier SCmA 4,360$2,0000.00%
FIRST MANHATTAN CO. LLC. 25,800$11,0000.00%
WELLS FARGO & COMPANY/MN 89$00.00%
NORTHERN TRUST CORP 12,516$5,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 217,078$93,0000.00%
View complete list of SCOPUS BIOPHARMA INC shareholders